(Q40937660)

25 September 2017

1 reference

title

Direct gene transfer for treatment of human cancer (English)

1 reference

25 September 2017

Nabel GJ

1

1 reference

25 September 2017

Yang ZY

2

1 reference

25 September 2017

Nabel EG

3

1 reference

25 September 2017

Bishop K

4

1 reference

25 September 2017

Marquet M

5

1 reference

25 September 2017

Felgner PL

6

1 reference

25 September 2017

Gordon D

7

1 reference

25 September 2017

Chang AE

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

Annals of the New York Academy of Sciences

25 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

772

1 reference

25 September 2017

227-231

1 reference

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution

25 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Natural killer cells: artifact to reality: an odyssey in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Immunotherapy of cancer using interleukin 2: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Immunotherapy of malignancy by in vivo gene transfer into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Polypetide mediator network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB44748.X

10.1111/J.1749-6632.1995.TB44748.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference